Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Dec 06, 2024

BUY
$6.87 - $26.45 $424,799 - $1.64 Million
61,834 New
61,834 $555,000
Q1 2024

May 15, 2024

SELL
$6.87 - $26.45 $13,588 - $52,318
-1,978 Reduced 3.1%
61,834 $555,000
Q4 2023

Feb 14, 2024

SELL
$11.28 - $25.46 $415,250 - $937,258
-36,813 Reduced 36.58%
63,812 $1.59 Million
Q2 2023

Aug 14, 2023

BUY
$16.06 - $21.61 $1.44 Million - $1.94 Million
89,667 Added 818.28%
100,625 $1.88 Million
Q1 2023

May 15, 2023

BUY
$17.19 - $30.8 $188,368 - $337,506
10,958 New
10,958 $201,000
Q3 2022

Mar 03, 2023

BUY
$17.96 - $30.46 $178,235 - $302,285
9,924 New
9,924 $238,000
Q3 2022

Nov 14, 2022

BUY
$17.96 - $30.46 $178,235 - $302,285
9,924 New
9,924 $239,000
Q1 2022

May 16, 2022

SELL
$17.02 - $40.22 $1.92 Million - $4.54 Million
-112,905 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$29.5 - $39.5 $14,543 - $19,473
-493 Reduced 0.43%
112,905 $4.15 Million
Q3 2021

Nov 15, 2021

SELL
$29.86 - $39.47 $238,252 - $314,931
-7,979 Reduced 6.57%
113,398 $3.52 Million
Q2 2021

Aug 16, 2021

SELL
$17.99 - $40.02 $32,274 - $71,795
-1,794 Reduced 1.46%
121,377 $3.86 Million
Q1 2021

May 17, 2021

SELL
$16.0 - $24.46 $327,184 - $500,182
-20,449 Reduced 14.24%
123,171 $2.74 Million
Q4 2020

Feb 16, 2021

BUY
$15.89 - $40.87 $241,130 - $620,202
15,175 Added 11.81%
143,620 $2.84 Million
Q3 2020

Nov 16, 2020

BUY
$21.6 - $37.5 $2.77 Million - $4.82 Million
128,445 New
128,445 $4.14 Million

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $24.9M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.